New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Overview of attention for article published in Blood Advances, January 2026

Altmetric Badge

About this Attention Score

High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 10 X users

bluesky: 1 Bluesky user

Readers on

mendeley: 14 Mendeley

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 30,062 followers.

RT @DrRaulCordoba: #Hematology New comorbidity index associated with survival after chimeric antigen receptor T-cell #CARTcell therapy for…

#Hematology New comorbidity index associated with survival after chimeric antigen receptor T-cell #CARTcell therapy for large B-cell #lymphoma #DLBCL #lymsm https://t.co/IUe9Rs5y9G

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.